Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables

Overview of attention for article published in Acta Neuropathologica Communications, December 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 69 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 4,093 followers.

Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics influence outcome and Audencel up-regulates Th1-related immunovariables. https://t.co/iTo3XuvzPp

05 Jun 2019

Reply Repost Favourite

04 Jun 2019

Reply Repost Favourite

11 Mar 2019

Reply Repost Favourite

RT @DCell_papers: Immunological analysis of phase II glioblastoma dendritic cell vaccine (Audencel) trial: immune system characteristics in…

10 Dec 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.